RedHill Biopharma (RDHL) Change in Inventory (2017 - 2022)
Historic Change in Inventory for RedHill Biopharma (RDHL) over the last 6 years, with Q4 2022 value amounting to $1.6 million.
- RedHill Biopharma's Change in Inventory rose 19286.56% to $1.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $3.8 million, marking a year-over-year increase of 14587.81%. This contributed to the annual value of $738000.0 for FY2024, which is 11743.44% up from last year.
- Per RedHill Biopharma's latest filing, its Change in Inventory stood at $1.6 million for Q4 2022, which was up 19286.56% from -$865000.0 recorded in Q3 2022.
- In the past 5 years, RedHill Biopharma's Change in Inventory ranged from a high of $2.6 million in Q2 2022 and a low of -$4.4 million during Q3 2021
- Its 5-year average for Change in Inventory is -$517850.0, with a median of -$325000.0 in 2018.
- Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 190506.33% in 2020, then soared by 40355.03% in 2022.
- Over the past 5 years, RedHill Biopharma's Change in Inventory (Quarter) stood at -$300000.0 in 2018, then skyrocketed by 126.33% to $79000.0 in 2019, then plummeted by 1905.06% to -$1.4 million in 2020, then decreased by 18.93% to -$1.7 million in 2021, then soared by 192.87% to $1.6 million in 2022.
- Its last three reported values are $1.6 million in Q4 2022, -$865000.0 for Q3 2022, and $2.6 million during Q2 2022.